Moderna, Seqirus and more—News of Note by Angus Liu Wednesday, February 13, 2019 Here is some other vaccine news of note for the week.
Novavax's NanoFlu bests Sanofi's Fluzone HD in seniors by Eric Sagonowsky Wednesday, January 9, 2019 Novavax's NanoFlu vaccine beat Sanofi's Fluzone HD in seniors in a midstage test, setting up the smaller company's shot for a move into phase 3.
Flu vaccination rates better so far this season: CDC by Eric Sagonowsky Tuesday, December 18, 2018 After a horrible flu season last year, more people have gotten vaccinations so far this year, according to the CDC.
Seqirus to spend $140M in N.C. flu vaccine plant expansion by Eric Sagonowsky Monday, November 19, 2018 Seqirus plans to add cell-based and adjuvanted flu vaccine capacity in a $140 million expansion to its plant in Holly Springs, North Carolina.
Altimmune, Ebola outbreak and more—News of Note by Eric Sagonowsky Wednesday, October 24, 2018 Here is some other vaccine news of note for the week.
Seqirus' cell-based Flucelvax nears first-ever EU approval by Eric Sagonowsky Tuesday, October 23, 2018 While Seqirus works to boost manufacturing for its cell-based flu vaccine in the U.S., the shot is nearing an approval in Europe.
Officials deny shortage of Seqirus' Fluad in the U.K. by Eric Sagonowsky Wednesday, October 17, 2018 Seqirus says it is phasing delivery of its flu vaccine Fluad to the U.K. ahead of the peak season, though pharmacists have reported a lack of supply.
Sanofi teams with ALA on flu-shot message to U.S. seniors by Eric Sagonowsky Monday, October 15, 2018 As Sanofi mobilizes millions of flu shots, it's working with the American Lung Association to make sure vaccines get to the people who need them.
Cell-derived flu strain provides a better match than eggs: study by Eric Sagonowsky Wednesday, October 10, 2018 Seqirus published data showing that cell-derived flu viruses matched better with circulating strains than egg-based counterparts.
Group calls for flu shots over AstraZeneca's FluMist this year by Eric Sagonowsky Tuesday, September 4, 2018 A group of pediatric experts has recommended injected vaccines over AstraZeneca's FluMist for the upcoming season.
